|
|
|
| Expression and significance of ING4 in human gastric cancer |
| CHENG Haiyan1, SHEN Zhe1, CHEN Weichang2, YAN Su2#br#
. |
1.Department of Digestion, Shaoxing Second Hospital, Shaoxing, 312000; 2.Department of Digestion, the First Affiliated Hospital of Soochow Medical University, Suzhou, 215006
|
|
| Cite this article: |
|
CHENG Haiyan,SHEN Zhe,CHEN Weichang, et al. Expression and significance of ING4 in human gastric cancer[J]. JOURNAL OF WEZHOU MEDICAL UNIVERSITY, 2016, 46(4): 284-286.
|
|
|
Abstract Objective: To study the expression and significance of inhibitor of growth family member 4 (ING4) in many kinds of human gastric cancer cells and gastic cancer tissue. Methods: In the experimental group, there were three different typs of gastric cancer cells, MKN-1 (high differentiation), SGC-7901 (moderate differentiation)and BGC-823 (low differentiation). In the control group, there was a normal gastric mucosal cells GES-1. All cell lines were cultured in vitro. The mRNA and protein expression of ING4 were analyzed by RT-PCR and Western blot. Whether there was ING4 protein expression in gastric cancer tissue and adjacent tissue by immunohistochemistry. Results: The mRNA and protein expression of ING4 in SGC-7901 and BGC-823 groups were significantly lower than that in MKN-1 and GES-1 groups. The difference was statistically significant (P<0.05). The mRNA and protein expression of ING4 in BGC-823 group were significantly lower than that in SGC-7901 group. The difference was statistically significant (P<0.05). But there was no significant different between MKN-1 group and GES-1 group (P>0.05). The positive rates of expression of ING4 protein in gastric cancer tissue was significantly lower than that in adjacent tissue, the difference was statistically significant (P<0.05). Conclusion: ING4 protein as a tumor suppressor is associated with the development and prognosis of the gastric cancer, which provide theoretical basis for clinical use ING4 gene targeted therapy for gastric cancer in the future.
|
|
Received: 18 January 2016
|
| |
|
|
|
[1] HERZOG T J, DINKELSPIEL H E. Fallopian tube removal: “stic-ing” it to ovarian cancer: what is the utility of prophylactic tubal removal[J]. Curr Oncol, 2013, 20(3): 148-151.
[2] SATPATHY S, NABBI A, RIABOWOL K. et al. Regulating chromatin regulators: post-translational modification of the ING famility of epigenetic regulators[J]. Biochem J, 2013, 450(3): 433-442.
[3] MORENO A, PALACIOS A, ORGAZ J L, et al. Functional impact of cancer-associated mutations in the tumor suppressor protein ING4[J].Carcinogenesis, 2010, 31(11): 1932-1938.
[4] LI X, KIKUCHI K, ZHENG Y, et al. Downregulation and translocation of nuclear ING4 is correlated with tumorigenesis and progression of head and neck squamous cell carcinoma[J]. Oral Oncology, 2011, 47(3): 217-223.
[5] LING C, XIE Y, ZHAO D, et al. Enhanced radiosensitivity of nonsmall-cell lung cancer (NSCLC) by adenovirus-mediated ING4 gene therapy[J]. Cancer Gene Ther, 2012, 19(10): 697-706.
[6] MCGRATH C E, TALLMAN K A, PORTERNA, et al. Structure-activity analysis of diffusible lipid electrophiles associated with phospholipid peroxidation: 4-hydroxynonenal and 4-oxonon analogues[J]. Chem Res Toxicol, 2011, 24(3): 357-370.
[7] ZENG Z L, LI F J, GAO F, et al. Upregulation of miR-650 is correlated with down-regulation of ING4 and progression of hepatocellular carcinoma[J]. J Surg Oncol, 2013, 107(2):105-110.
[8] SHI J L, TIAN L F, HONG T L, et al. Tumor suppressor ING4 overexpression contributes to proliferation and invasion inhibition in gastric carcinoma by suppressing the NF-KB signaling pathway[J]. Mol Biol Rep, 2013, 40(10):5723-5732.
[9] 钱莉, 董晓荣, 李贵玲, 等. 胃癌组织ING4和HIF-1α及VEGF表达的相关性分析[J]. 中华肿瘤防治杂志, 2012, 19(8): 600-603.
|
|
|
|
